期刊文献+

不同剂型甲钴胺治疗糖尿病周围神经病变的疗效研究 被引量:4

Curative Effect Observation with Different Dosage Form of Methylcobalamin in the Treatment of Diabetic Peripheral Neuropathy
下载PDF
导出
摘要 目的探讨甲钴胺不同剂型对糖尿病周围神经病变的疗效。方法将67例糖尿病周围神经病变患者随机分成两组。A组32例,给予甲钴胺0.5mg,肌肉注射,1次/d;B组35例,给予甲钴胺片0.5mg,口服,3次/d,疗程均为2周。分别于用药前、用药2周后进行疗效判定和症状评分(TSS)。结果治疗后两组患者神经症状及TSS评分较治疗前明显好转,且A组优于B组。结论甲钴胺可有效改善糖尿病周围神经病变,且肌肉注射组优于口服给药组。 Objective To probe into the therapeutic effectiveness of methylcobalamin administered by different dosage form in patients with diabetes peripheral neuropathy. Methods 67 cases of diabetic peripheral neuropathy patients were randomly divided into two groups,A group of 32 cases,giving methylcobalamin 0.5 mg,im,Qd;B group 35 examples,giving methylcobalamin piece of 0.5 mg,Po,Tid,the period of treatment lasted 2 weeks.Then evaluate respectively on the nerve symptoms and symptom score(TSS) before and after 2 weeks. Results Compared with before treatment,the nerve symptoms and TSS score of two groups are improved significantly after treatment,and the group A is better than that of group B. Conclusion Methylcobalamin can effectively improve diabetes peripheral neuropathy,and intramuscular injection group is better than that of oral medicine group.
作者 徐薇
出处 《临床合理用药杂志》 2013年第15期14-15,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 甲钴胺 糖尿病 周围神经病变 治疗结果 Methylcobalamin Diabetes mellitus Peripheral neuropathy Treatment outcome
  • 相关文献

参考文献9

二级参考文献42

  • 1Erol Cerasi.胰岛素生成,胰岛素分泌及2型糖尿病:问题的核心在于β细胞(英文)[J].中华内分泌代谢杂志,2005,21(3):194-198. 被引量:86
  • 2任婷婷,郭晓蕙.定量感觉检查在糖尿病周围神经病变诊断中的应用价值[J].中华糖尿病杂志(1006-6187),2005,13(5):357-359. 被引量:19
  • 3Schmeichel AM,Schmelzer JD,Low PA.Oxidative injury and apoptosisof dorsal root ganglion neurons in chronic experimental diabetic neurop-athy[J].Diabetes,2003,52(1):165-9.
  • 4Amemiya S, Kato K, Asayama K. The improved response in endogenous insulin due to continuous subcutaneous infusion of insulin therapy in juvenile diabetes. Tohoku J Exp Med, 1983,141 (Suppl) :713-717.
  • 5Garvey WT, Olefsky JM, Griffin J, et al. The effect of insulin treatment on insulin secretion and insulin action in type Ⅱ diabetes mellitus. Diabetes, 1985,34:222-234.
  • 6Glaser B, Leibovich G, Nesher R, et al. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinol, 1988,118:365-373.
  • 7llkova H, Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20 : 1353-1356.
  • 8Yoshioka K, Yoshida T, Yoshikawa T. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes: response to Ryan, lmes,and Wallace. Diabetes Care, 2004,27:2281-2282.
  • 9Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of B-cell function. Diabetes Care, 2004,27:2597-2602.
  • 10Rasouli N, Elbein SC. Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab, 2004,89 : 6331 -6335.

共引文献324

同被引文献33

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部